# Real-World Data of Clinicopathological Characteristics and Management of Breast Cancer Patients According to HER2 Status

> **NCT05217381** · — · COMPLETED · sponsor: **MedSIR** · enrollment: 18533 (actual)

## Conditions studied

- Early Breast Cancer
- Metastatic Breast Cancer
- Locally Advanced Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05217381
- **Lead sponsor:** MedSIR
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-22
- **Primary completion:** 2023-09-20
- **Final completion:** 2023-09-20
- **Target enrollment:** 18533 (ACTUAL)
- **Last updated:** 2023-09-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05217381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05217381, "Real-World Data of Clinicopathological Characteristics and Management of Breast Cancer Patients According to HER2 Status". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05217381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
